Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-328-9 | CAS number: 81-14-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Gene mutation (Bacterial Reverse Mutation Assay/Ames test): The substance musk ketone did not induce mutagenicity in S. typhimurium TA 98, TA 100, TA 1535, TA 1537 and E. coli WP2 uvr A in the presence or absence of phenobarbital/β-naphthoflavone-induced rat liver S9 metabolic activation (OECD 471, GLP).
In vitro cytogenicity (chromosome aberration) study in mammalian cells: the substance musk ketone was concluded to be negative for the induction of chromosome aberrations in the presence and absence of Aroclor 1254-induced rat liver S9 metabolic activation in CHO-K1 cells. (Equivalent or similar to OECD 473).
Gene mutation (mammalian cell gene mutation assay): there was no evidence of induced mutant colonies over background in L5178Y mouse lymphoma cells exposed to musk ketone in the presence or absence of Aroclor-induced -induced rat liver S9 mammalian metabolic activation (Equivalent or similar to OECD 476/GLP).
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 December 2016 - 07 March 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: International Flavors & Fragrances; 0008085963
- Expiration date of the lot/batch: 20 August 2018
- Purity: 99.8%
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature in the dark
- Stability under test conditions: The test item was accurately weighed and approximate half-log dilutions prepared in dimethyl sulphoxide by mixing on a vortex mixer and sonication for 10 minutes at 40 °C on the day of each experiment. No correction for purity was required. Prior to use, the solvent was dried to remove water using molecular sieves i.e. 2 mm sodium alumino-silicate pellets with a nominal pore diameter of 4 x 10-4 microns. All formulations were used within four hours of preparation and were assumed to be stable for this period. - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/β-naphthaflavone induced rat liver S9
- Test concentrations with justification for top dose:
- Experiment 1 (plate incorporation; + and -S9): 1.5, 5, 15, 50, 150, 500, 1500 and 5000 μg/plate
Experiment 1 (pre-incubation; + and -S9): 15, 50, 150, 500, 1500, 5000 μg/plate - Vehicle / solvent:
- The test item was insoluble in sterile distilled water at 50 mg/mL but was fully soluble in dimethyl sulphoxide at the same concentration and acetone at 100 mg/mL in solubility checks performed in-house. Dimethyl sulphoxide was selected as the vehicle.
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- benzo(a)pyrene
- other: 2-Aminoanthracene (2AA)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
Experiment 1: in agar (plate incorporation);
Experiment 2: preincubation
DURATION
- Preincubation period: 20 mins
- Exposure duration: Approximately 48 hours for both experiments
NUMBER OF REPLICATIONS: Triplicate
DETERMINATION OF CYTOTOXICITY
- Method: reduction in the growth of the bacterial background lawn - Evaluation criteria:
- There are several criteria for determining a positive result. Any, one, or all of the following can be used to determine the overall result of the study:
1. A dose-related increase in mutant frequency over the dose range tested.
2. A reproducible increase at one or more concentrations.
3. Biological relevance against in-house historical control ranges.
4. Statistical analysis of data as determined by UKEMS.
5. Fold increase greater than two times the concurrent solvent control for any tester strain (especially if accompanied by an out-of-historical range response.
A test item will be considered non-mutagenic (negative) in the test system if the above criteria are not met.
Although most experiments will give clear positive or negative results, in some instances the data generated will prohibit making a definite judgment about test item activity. Results of this type will be reported as equivocal. - Statistics:
- Statistical significance was confirmed by using Dunnetts Regression Analysis (* = p < 0.05) for those values that indicate statistically significant increases in the frequency of revertant colonies compared to the concurrent solvent control.
- Species / strain:
- other: S. typhimurium strains TA1535, TA1537, TA98 and TA100; E. coli WP2uvrA
- Remarks:
- Experiment 1
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- other: S. typhimurium strains TA1535, TA1537, TA98 and TA100; E. coli WP2uvrA
- Remarks:
- Experiment 2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Manual counts were performed at 5000 μg/plate because of test item precipitation (Experiment 1). Manual counts were performed at and above 1500 μg/plate because of test item precipitation. (Experiment 2).
HISTORICAL CONTROL DATA (with ranges, means and standard deviation)
- Positive historical control data: The historical ranges of the positive control reference items for 2015 and 2016 are presented in Appendix 1.
- Negative (solvent/vehicle) historical control data: Combined historical negative and solvent control ranges for 2015 and 2016 are presented in Appendix 1. - Conclusions:
- In a reverse bacterial mutation assay (Ames test), musk ketone was negative with and without metabolic activatiion.
- Executive summary:
In a reverse gene mutation assay in bacteria (QC11WT), strains of S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2 uvr A were exposed to musk ketone (99.8%) in DMSO at concentrations of 1.5, 5, 15, 50, 150, 500, 1500 and 5000μg/plate (plate incorporation; experiment 1) and 15, 50, 150, 500, 1500, 5000 μg/plate (20 minute pre-incubation; experiment 2) in the presence and absence of mammalian metabolic activation (Phenobarbital/β-naphthoflavone-induced rat liver S9).
Musk ketone was tested up to the limit concentration (5000 µg/plate). The positive controls induced the appropriate responses in the corresponding strains. There was no evidence of induced mutant colonies over background.
This study is classified as acceptable. This study satisfies the requirement for Test Guideline OECD 471 for in vitro mutagenicity (bacterial reverse gene mutation) data.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- GLP compliance:
- not specified
- Type of assay:
- in vitro mammalian chromosome aberration test
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Firmenich Incorporated (Princeton, N J, USA); 65659.9305.
- Purity: >99%
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Stored at 2-6°C and protected from exposure to light. - Species / strain / cell type:
- other: CHO-K1
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: American Type Culture Collection, Rockville, MD, USA - Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S9
- Test concentrations with justification for top dose:
- 24 and 48 hrs; -S9: 4.3, 8.5, 17 and 34 µg/ml
4 hr; +S9: 1.25, 2.5, 5 and 10 µg/ml (24 and 48 hr harvest)
4 hr; +S9: 8, 10, 12 and 14 µg/ml (24 hr harvest) - Vehicle / solvent:
- Acetone
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- triethylenemelamine
- cyclophosphamide
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
- Cell density at seeding: 3 x 10~5 cells/25cm2 flask (24-hr harvest) or 1 x 10~5 cells/25cm2 flask (48-hr harvest)
DURATION
- Exposure duration: In the non-activated study, the cells were continuously exposed to treatment in the incubator at 37 ±1°C prior to harvest at approximately 24 or 48 hr. In the S9 activated study, the cells were exposed to treatment in the incubator for 4 hr at 37 ±1°C.
- Expression time (cells in growth medium): After the exposure period, medium was removed, the cells washed with calcium and magnesium-free phosphate buffered saline, re-fed with complete medium and returned to the incubator until harvest at approximately 24 or 48 hr.
SPINDLE INHIBITOR (cytogenetic assays): Two hours prior to the scheduled cell harvest, Colcemid was added to duplicate flasks for each treatment condition (activated and non-activated studies) at a final concentration of 0.1 µg/ml and the flasks incubated for an additional 2 hr.
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: Metaphase cells with 20 + 2 centromeres were examined under oil immersion without prior knowledge of treatment groups.
NUMBER OF METAPHASE SPREADS ANALYSED PER DOSE (if in vitro cytogenicity study in mammalian cells): Whenever possible, a minimum of 200 metaphase spreads (100/duplicate flask) were examined and scored for chromatid-type and chromosome-type aberrations. Chromatid and isochromatid gaps were recorded but not included in the analysis.
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index (The mitotic index was recorded as the percentage of cells in mitosis/500 cells counted); cloning efficiency.
OTHER EXAMINATIONS:
- Determination of polyploidy: Polyploidy was evaluated as the percentage of polyploid cells/100 metaphase cells
counted. - Statistics:
- P ≤0.025, one-sided Fisher's exact test.
- Species / strain:
- other: CHO-K1
- Remarks:
- 24 hr
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- other: CHO-K1
- Remarks:
- 48 hrs
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- other: CHO-K1
- Remarks:
- 4 hr (24 hr harvest)
- Metabolic activation:
- with
- Genotoxicity:
- other: structural aberrations at 10 µg/ml only
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- other: CHO-K1
- Remarks:
- 4 hrs (48 hr harvest)
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- other: CHO-K1
- Remarks:
- 4 hr (24 harvest repeat)
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Specific cytotoxicity data was not provided. The authors indicated that cytotoxicity based on percent relative cloning efficiency was satisfactory to provide adequate metaphase cells for examination of chromosomal aberrations.
- Conclusions:
- Musk ketone is negative in the mammalian cytogenetic assay using CHO-K1 cells
- Executive summary:
In an in vitro cytogenicity (chromosome aberration) study in mammalian cells (Api et al., 1996), CHO-K1 cells were exposed to musk ketone (>99%) in acetone. In the presence of metabolic activation (Aroclor 1254-induced rat liver S9), cells were exposed to 1.25, 2.5, 5 and 10 µg/ml for 4 hours (24 and 48 hr harvest) and 8, 10, 12 and 14 µg/ml for 4 hours (24 hr harvest). In the absence of metabolic activation, cells were exposed to 4.3, 8.5, 17 and 34 µg/ml for 24 and 48 hours.
Cytotoxicity was satisfactory to provide adequate metaphase cells for examination of chromosomal aberrations. Positive controls induced the appropriate response. There was no evidence of a statistically significant increase in chromosomal aberrations without metabolic activation or with metabolic activation for 4 hours (48 hour harvest time point). At the dose level of 10.0 µg/ml, there was a statistically significant increase (12%) in structural aberrations, but not numerical aberrations, in the presence of metabolic activation at the 24-hr harvest time point. In a confirmatory assay with dose levels of 8, 10, 12 and 14.0 µg/ml, in the presence of metabolic activation at the 24-hr harvest time point, there was no significant increase in structural or numerical aberrations. On the basis of the overall findings and the non-reproducibility at a single dose level, it was concluded that musk ketone is negative in the mammalian cytogenetic assay using CHO-K1 cells.
This study is classified as acceptable. This study satisfies the requirement for Test Guideline [In vitro mammalian cytogenetics [Chromosome aberration]] OECD 473 for in vitro cytogenetic mutagenicity data.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 01 July 1993 to 13 December 1993
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- OECD 476 (21 July 1997)
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell gene mutation tests using the thymidine kinase gene
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Firmenich Incorporated (Princeton, N J, USA); 65659.9305.
- Purity: >99%
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Stored at 2-6°C and protected from exposure to light. - Target gene:
- Thymidine kinase
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: Dr Donald Clive, Burroughs Wellcome Company, Research Triangle Park, NC, USA.
MEDIA USED
- Type and identity of media including CO2 concentration if applicable: Maintained in Fischers’ Medium for Leukemic Cells of Mice with 0.1% Pluronics supplemented with 10% horse serum and 4mM L-glutamine. Gassed at 5 ±1% CO2 in air.
- Properly maintained: Yes
- Periodically 'cleansed' against high spontaneous background: Cleansed before use in the assay - Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor-induced rat liver S9
- Test concentrations with justification for top dose:
- Preliminary test: 0.5 - 4000 µg/ml
Mutagenesis assays
-S9: 100 – 4000 µg/ml
+S9: 1.0 – 100 µg/ml
Mutagenesis assays: selected for cloning
-S9: 700 – 4000 µg/ml
+S9: 2.0 – 35 µg/ml - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone; lot no. 920807 (Fischer Chemical Company)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- methylmethanesulfonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4 hrs + and – S9.
- Expression time (cells in growth medium): 48 hrs
- Selection time (if incubation with a selection agent): 10-12 days
SELECTION AGENT (mutation assays): Trifluorothymidine
DETERMINATION OF CYTOTOXICITY
- Method: relative suspension growth (preliminary test); relative total growth (main tests) - Evaluation criteria:
- In the evaluation of the data, increases in mutant frequencies which occur only at highly toxic concentrations are not considered biologically relevant. The following criteria are considered:
Positive: A test article producing a concentration-related increase in mutant frequency with more than one dose level in the 10% or greater total growth range exhibiting a mutant frequency which is 2-fold greater than the background level will be considered positive.
Equivocal: A test article producing no concentration-related increase in mutant frequency but any one dose level in the 10% or greater total growth range exhibiting a mutant frequency which is 2-fold greater than the background level will be considered equivocal.
Negative: A test article producing no concentration-related increase in mutant frequency and no 2-fold or greater increase above the background in dose levels in the 10% or greater total growth range will be considered negative. - Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- 30 µg/ml
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of osmolality: The osmolality of the solvent control was 410 mOsm/kg and the osmolality of the top dose, 4000 µg/ml, was 363 mOsm/kg.
RANGE-FINDING/SCREENING STUDIES: A preliminary toxicity test based on cell population growth relative to the solvent controls. Cells were exposed to solvent alone and 9 concentrations of the test article ranging from 0.5 – 4000 µg/ml for 4 hrs in the absence and presence of metabolic activation. A high dose of 5000 µg/ml could not be achieved in acetone due to a lack of solubility. Cell population density was determined 24 and 48 hrs after exposure.
- Conclusions:
- Under the conditions of this MLA in L5178Y cells, musk ketone was negative in the presence and absence of Aroclor-induced rat liver S9 metabolic activation.
- Executive summary:
In a mammalian cell gene mutation assay (thymidine kinase MLA; 23793), mouse lymphoma L5178Y cells cultured in vitro were exposed to musk ketone (>99%) in acetone at concentrations of 700 – 4000 µg/ml in the absence and 2.0 – 35 µg/ml in the presence of mammalian metabolic activation (Aroclor-induced rat liver S9) for 4 hours.
Musk ketone was tested up to cytotoxic concentrations in the presence of metabolic activation and up to precipitating concentrations in the absence of metabolic activation. The positive controls induced the appropriate response. There was no evidence of induced mutant colonies over background.
This study is classified as acceptable. This study satisfies the requirement for OECD 476 for in vitro mutagenicity (mammalian cell gene mutation) data.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Gene mutation (Bacterial Reverse Mutation Assay/Ames test)
There is one in vitro gene mutation study (reverse gene mutation assay/Ames test in bacteria) available.
In a reverse gene mutation assay in bacteria (OECD 471/GLP), strains of S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2 uvr A were exposed to musk ketone (99.8%) in DMSO at concentrations of 1.5, 5, 15, 50, 150, 500, 1500 and 5000μg/plate (plate incorporation; experiment 1) and 15, 50, 150, 500, 1500, 5000 μg/plate (20 minute pre-incubation; experiment 2) in the presence and absence of mammalian metabolic activation (Phenobarbital/β-naphthoflavone-induced rat liver S9). Musk ketone was tested up to the limit concentration (5000 µg/plate). The positive controls induced the appropriate responses in the corresponding strains. There was no evidence of induced mutant colonies over background.
In vitro cytogenicity (chromosome aberration) study in mammalian cells:
There is one in vitro cytogenicity (chromosome aberration) study in mammalian cells available.
In an in vitro cytogenicity (chromosome aberration) study in mammalian cells (Equivalent or similar to OECD 473), CHO-K1 cells were exposed to musk ketone (>99%) in acetone. In the presence of metabolic activation (Aroclor 1254-induced rat liver S9), cells were exposed to 1.25, 2.5, 5 and 10 µg/ml for 4 hours (24 and 48 hr harvest) and 8, 10, 12 and 14 µg/ml for 4 hours (24 hr harvest). In the absence of metabolic activation, cells were exposed to 4.3, 8.5, 17 and 34 µg/ml for 24 and 48 hours. Cytotoxicity was satisfactory to provide adequate metaphase cells for examination of chromosomal aberrations. Positive controls induced the appropriate response. There was no evidence of a statistically significant increase in chromosomal aberrations without metabolic activation or with metabolic activation for 4 hours (48 hour harvest time point). At the dose level of 10.0 µg/ml, there was a statistically significant increase (12%) in structural aberrations, but not numerical aberrations, in the presence of metabolic activation at the 24-hr harvest time point. In a confirmatory assay with dose levels of 8, 10, 12 and 14.0 µg/ml, in the presence of metabolic activation at the 24-hr harvest time point, there was no significant increase in structural or numerical aberrations. On the basis of the overall findings and the non-reproducibility at a single dose level, it was concluded that musk ketone is negative in the mammalian cytogenetic assay using CHO-K1 cells.
Gene mutation (mammalian cell gene mutation assay):
There is one gene mutation (mammalian cell gene mutation assay) available.
In a mammalian cell gene mutation assay (Equivalent or similar to OECD 476/GLP), mouse lymphoma L5178Y cells cultured in vitro were exposed to musk ketone (>99%) in acetone at concentrations of 700 – 4000 µg/ml in the absence and 2.0 – 35 µg/ml in the presence of mammalian metabolic activation (Aroclor-induced rat liver S9) for 4 hours. Musk ketone was tested up to cytotoxic concentrations in the presence of metabolic activation and up to precipitating concentrations in the absence of metabolic activation. The positive controls induced the appropriate response. There was no evidence of induced mutant colonies over background.
All three studies are negative and the results are suitable for use in the human health hazard assessment.
Justification for classification or non-classification
Based on the available information in the dossier, the substance musk ketone (CAS No. 81-14-1) does not need to be classified for germ cell mutagenicity when the criteria outlined in Annex I of 1272/2008/EC are applied.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.